Journal · Cell biology · Updated 21 November 2026
Cytotechnology
Read Cytotechnology articles on DeepDyve. No university library needed.
Cytotechnology publishes cell-based research, from ferroptosis in the placenta in preeclampsia to plant compounds tested on colorectal and liver cancer cells and the immune cells behind neuropathic pain. Springer Nature publishes it. Cytotechnology has published since 1987. A DeepDyve subscription lets you read it in full, alongside millions of articles from other journals licensed from publishers including Springer Nature.
Then $59 a month or $499 a year. A credit card is required; cancel during the trial and you won’t be charged. You read articles online; PDFs are sold separately.
Personal plans aren’t for business use. Reading for work? See Enterprise.
Cytotechnology at a glance
- Full title
- Cytotechnology
- Abbreviation (NLM)
- Cytotechnology
- Publisher
- Springer Nature
- Print ISSN
- 0920-9069
- Online ISSN (eISSN)
- 1573-0778
- First published
- 1987
- Subjects
- Biotechnology, Genetics
- Access model
- Hybrid (6% free to read in 2026)
Ways to access Cytotechnology
6% of the articles Cytotechnology published from January 1 to November 19, 2026 are open access and free to read. For the rest, look for the authors’ manuscript, check a library, or read them on DeepDyve.
- Open access articles. 6% of Cytotechnology articles published from January 1 to November 19, 2026 carry a Creative Commons license, per Crossref, and are free to read. They’re marked “Open access” below.
- The authors’ accepted manuscript. For subscription articles, Springer Nature lets authors post their accepted manuscript on their own website as soon as it’s accepted, and in a repository such as PubMed Central 12 months after publication.
- Ask the authors. Authors can also share a free, read-only link to their published article through Springer Nature’s SharedIt, so it’s worth asking the authors directly.
- NIH-funded research. For papers accepted on or after July 1, 2025, the US National Institutes of Health requires the accepted manuscript in PubMed Central, free with no embargo from the official publication date.
- A library. Your university, hospital or public library may subscribe to Cytotechnology. Check its journal list and whether it offers remote access.
- DeepDyve. Read Cytotechnology articles online for $59 a month or $499 a year after a free first month. Articles marked LitStream below are in DeepDyve’s LitStream collection, which a subscription lets you read online. PDFs are sold separately, and availability varies by article.
Sources: Springer Nature self-archiving policy; NIH Public Access Policy; open access share from Crossref license data.
Impact factor and metrics
Cytotechnology’s 2025 Journal Impact Factor is 2.2, and its 5-year Impact Factor is 2.2.
2.2
Journal Impact Factor (2025)
2.2
5-year Impact Factor (2025)
22 days
Median time to first decision
Source: journal metrics on the Cytotechnology homepage (Springer Nature), checked November 21, 2026. Impact Factor from Clarivate Journal Citation Reports.
Recent Cytotechnology research worth reading
Published January to April 2026. Summaries describe what the authors report.
-
MiR-150-3p as a diagnostic biomarker and regulator of ferroptosis in preeclampsia via targeting FTH1
The authors report that miR-150-3p is markedly raised in preeclampsia placentas, distinguishes the condition with an AUC of 0.868, and promotes ferroptosis in trophoblast cells by directly lowering FTH1, increasing iron buildup, lipid peroxidation and oxidative stress.
Geng et al. · Cytotechnology, published online January 20, 2026 · DOI 10.1007/s10616-026-00896-x
-
Baicalein suppresses colorectal cancer progression through dual inhibition of the Wnt/β–catenin and PI3K/AKT/mTOR signaling pathways
In SW480 and HCT116 colorectal cancer cells, the authors report that baicalein reduced proliferation, migration and colony formation and increased apoptosis, acting by inhibiting both Wnt/β-catenin and PI3K/AKT/mTOR signaling in a time- and concentration-dependent way.
Anlei et al. · Cytotechnology, published online April 13, 2026 · DOI 10.1007/s10616-026-00959-z
-
Resveratrol coordinates apoptosis and autophagy in hepatocellular carcinoma cells via p53 acetylation: An integrative network pharmacology and experimental validation study
Combining network pharmacology with cell experiments, the authors report that resveratrol induced both apoptosis and autophagy in p53-wild-type HepG2 liver cancer cells by enhancing p53 acetylation at lysine 382, effects that were absent in p53-null Hep3B cells.
Zhang et al. · Cytotechnology, published online April 30, 2026 · DOI 10.1007/s10616-026-00973-1
-
Theranekron modulates extracellular matrix and apoptotic signaling pathways in colorectal cancer cells
Testing Theranekron D6, a Tarantula cubensis extract, on Caco-2 colorectal cancer cells, the authors report an IC₅₀ of 400 µL/mL at 48 h, a 23-fold rise in PDK1, a TIMP1-dominant matrix profile and lower MMP2 and MMP28 protein levels.
Kuccukturk et al. · Cytotechnology, published online March 16, 2026 · DOI 10.1007/s10616-026-00929-5
-
Pedunculoside attenuates the progression of neuropathic pain by affecting microglial polarization through Inhibition of the TLR4-NF-κB pathway
The authors report that pedunculoside shifted microglia from the M1 toward the M2 phenotype and reduced inflammation by inhibiting the TLR4-NF-κB pathway, both in stimulated BV2 cells and in mice with nerve injury, where it also eased pain sensitivity.
Huang et al. · Cytotechnology, published online January 20, 2026 · DOI 10.1007/s10616-026-00894-z
Related journals
Questions about Cytotechnology
How can I read Cytotechnology articles without a subscription?
6% of Cytotechnology articles published from January 1 to November 19, 2026 are open access and free to read. For subscription articles, Springer Nature lets authors post their accepted manuscript on their own website as soon as it’s accepted, and in a repository such as PubMed Central 12 months after publication. Your library may also subscribe. DeepDyve lets you read Cytotechnology articles online for $59 a month or $499 a year after a free first month.
What is the abbreviation for Cytotechnology?
Cytotechnology isn’t abbreviated: its NLM (PubMed) abbreviation is simply Cytotechnology.
What is the ISSN of Cytotechnology?
The print ISSN is 0920-9069 and the online ISSN is 1573-0778.
What is the impact factor of Cytotechnology?
Cytotechnology’s Journal Impact Factor is 2.2 (2025), and its 5-year Impact Factor is 2.2, according to Springer Nature’s published metrics.
Is Cytotechnology open access?
Cytotechnology is a hybrid journal: most articles are published under the subscription model, and authors can choose to publish open access. From January 1 to November 19, 2026, 14 of 216 Cytotechnology articles (6%) carry a Creative Commons license, per Crossref.
Cytotechnology articles on DeepDyve are licensed from Springer Nature. Journal facts as of 21 November 2026.
Start reading Cytotechnology today
One month free, then less than $2 a day. Cytotechnology, plus millions of articles from thousands of journals.






